<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03557502</url>
  </required_header>
  <id_info>
    <org_study_id>UOregon</org_study_id>
    <nct_id>NCT03557502</nct_id>
  </id_info>
  <brief_title>Heat Therapy Versus Exercise Training in Hypertension</brief_title>
  <official_title>Heat Therapy Versus Exercise Training in Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oregon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Oregon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a clinical trial to determine whether 30 sessions of heat therapy in the form of hot
      water immersion is better than 30 sessions of traditional aerobic exercise training on blood
      pressure reduction in people with elevated or Stage 1 hypertension.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypertension accounts for more cardiovascular disease related deaths than any other
      modifiable risk factor. While exercise training can be effective at reducing blood pressure
      in some individuals, many people do not respond to exercise training, and many more are
      unwilling to undergo regular exercise training. Alternative options need to be explored. This
      is a clinical trial to determine whether 30 sessions of heat therapy in the form of hot water
      immersion is better than 30 sessions of traditional aerobic exercise training on blood
      pressure reduction in people with elevated or Stage 1 hypertension. The investigators will
      evaluate known biomarkers of arterial stiffness and blood vessel health. It is hypothesized
      that heat therapy will be superior to exercise training on blood pressure reduction.
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    All Clinical Trials at Univ Oregon halted due to COVID-19 pandemic
  </why_stopped>
  <start_date type="Actual">December 1, 2019</start_date>
  <completion_date type="Anticipated">September 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized parallel study design</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Pressure Reduction</measure>
    <time_frame>10 weeks</time_frame>
    <description>A reduction in blood pressure following 30 sessions of intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arterial Stiffness</measure>
    <time_frame>10 weeks</time_frame>
    <description>A reduction in arterial pulse wave velocity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sympathetic Outflow</measure>
    <time_frame>10 weeks</time_frame>
    <description>A reduction in muscle sympathetic outflow</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hypertension</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Arterial Hypertension</condition>
  <arm_group>
    <arm_group_label>Heat Therapy Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group will undergo 30 sessions of heat therapy over approximately 10 weeks. Sessions will require subjects to be immersed in hot water for up to 45 minutes per session.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aerobic Exercise Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group will undergo 30 sessions of aerobic exercise training over approximately 10 weeks. Sessions will require subjects to exercise on a cycle ergometer for up to 45 minutes per session.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Heat Therapy Group</intervention_name>
    <description>30 sessions of immersion in 40.5 degree celsius water for 45 minutes per session</description>
    <arm_group_label>Heat Therapy Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aerobic Exercise Group</intervention_name>
    <description>30 sessions of aerobic exercise training for 45 minutes at 60% of VO2peak</description>
    <arm_group_label>Aerobic Exercise Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Systolic Blood Pressure 120 mmHg or greater and less than 140 mmHg or Diastolic Blood
             Pressure of 80 or greater and less than 80 mmHg.

        Exclusion Criteria:

          -  Secondary hypertension; diagnosed cardiovascular disease other than hypertension;
             taking anti-hypertensive drugs; BMI of 35 or greater; fasting glucose greater than 125
             mg/dl; women who are pregnant, nursing, or desiring to become pregnant.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher T Minson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oregon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Oregon</name>
      <address>
        <city>Eugene</city>
        <state>Oregon</state>
        <zip>97403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>June 4, 2018</study_first_submitted>
  <study_first_submitted_qc>June 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 15, 2018</study_first_posted>
  <last_update_submitted>May 8, 2020</last_update_submitted>
  <last_update_submitted_qc>May 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stage 1 hypertension</keyword>
  <keyword>Arterial Stiffness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified data will be placed in Research Electronic Data Capture (REDCap)</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>1 year following completion of subject testing</ipd_time_frame>
    <ipd_access_criteria>Access to REDCap</ipd_access_criteria>
    <ipd_url>http://www.project-redcap.org</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

